Key Updates for Week 39 ending September 30, 2023:

- Influenza activity remains low in the United States.
- In clinical laboratories, 1.0% of specimens tested positive for influenza, with a predominance of Influenza A (64.0%) and Influenza B (36.0%).
- In public health laboratories, 95 specimens tested positive for influenza, with Influenza A (84.2%) and Influenza B (15.8%) reported.
- For outpatient illness surveillance, 2.1% of patient visits were due to respiratory illness with fever and cough or sore throat.
- ILI activity varied by jurisdiction, with very high activity in New York City and Alaska, and minimal activity in most other jurisdictions.
- Geographically, local influenza activity was reported in Alabama, Kentucky, Louisiana, and Nevada, while sporadic activity was reported in 40 states and the District of Columbia.
- Pneumonia and influenza mortality data indicated that 7.3% of deaths during week 39 were attributed to pneumonia, influenza, and/or COVID-19.
- One influenza-associated pediatric death was reported during week 39, bringing the total for the season to 177.

These facts indicate that influenza activity remains low overall, with variations in activity across different jurisdictions. Virologic surveillance shows a mix of Influenza A and B viruses circulating. Outpatient illness surveillance detects a small percentage of visits for respiratory illness, and ILI activity varies geographically. Hospitalization and mortality rates remain relatively low, with one pediatric death reported.